Implantation Trends and Patient Profiles for Pacemakers and Implantable Cardioverter Defibrillators in the United States: 1993–2006

Background: Prior studies of cardiac rhythm management devices (pacemakers [PM] and implantable cardioverter defibrillators [ICD]) utilization in the United States have been limited to the Medicare population. We evaluated the national trends for the implantation of PMs and ICDs including the burden of device replacement.

[1]  S. Kurtz,et al.  Prosthetic joint infection risk after total hip arthroplasty in the Medicare population. , 2009, The Journal of arthroplasty.

[2]  Dario Gregori,et al.  Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07. , 2008, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  H. Mond,et al.  The World Survey of Cardiac Pacingand Cardioverter‐Defibrillators: Calendar Year 2005 An International Cardiac Pacing andElectrophysiology Society (ICPES) project , 2008, Pacing and clinical electrophysiology : PACE.

[4]  A. Moss,et al.  Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. , 2008, Journal of the American College of Cardiology.

[5]  G. Lamas,et al.  Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). , 2007, Heart rhythm.

[6]  B. Lindsay,et al.  Review of the registry's first year, data collected, and future plans. , 2007, Heart rhythm.

[7]  R. Passman,et al.  Sudden Death Prevention With Implantable Devices , 2007, Circulation.

[8]  A. Proclemer,et al.  Impact of the Main Implantable Cardioverter‐Defibrillator Trials for Primary and Secondary Prevention in Italy: A Survey of the National Activity During the Years 2001–2004 , 2006, Pacing and clinical electrophysiology : PACE.

[9]  Alvin I Mushlin,et al.  The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. , 2006, Journal of the American College of Cardiology.

[10]  Z. Goldberger,et al.  Implantable cardioverter-defibrillators: expanding indications and technologies. , 2006, JAMA.

[11]  W. Stevenson,et al.  Predicting early mortality after implantable defibrillator implantation: a clinical risk score for optimal patient selection. , 2006, American heart journal.

[12]  G. Gregoratos.  Indications and recommendations for pacemaker therapy. , 2005, American family physician.

[13]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[14]  G. Naccarelli.  Implantable cardioverter-defibrillators: expanding indications , 2004, Current opinion in cardiology.

[15]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[16]  Hugh Calkins,et al.  Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. , 2004, The New England journal of medicine.

[17]  J. Morgan.  The MADIT II and COMPANION studies: will they affect uptake of device treatment? , 2004, Heart.

[18]  A. Coats.  Omapatrilat--the story of Overture and Octave. , 2002, International journal of cardiology.

[19]  R. Kerber,et al.  ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices , 2002 .

[20]  R. Kerber,et al.  ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). , 2002, Circulation.

[21]  S. Raj,et al.  The implantable cardioverter-defibrillator: does everybody need one? , 2001, Progress in cardiovascular diseases.

[22]  A. Moss,et al.  Survival benefit with an implanted defibrillator in relation to mortality risk in chronic coronary heart disease. , 2001, The American journal of cardiology.

[23]  J. Zaidan.  Implantable cardioverter-defibrillators. , 1999, Journal of cardiothoracic and vascular anesthesia.

[24]  M A Hlatky,et al.  ACC/AHA Guidelines for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Executive Summary--a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). , 1998, Circulation.

[25]  M. Keller,et al.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. , 1997, The New England journal of medicine.

[26]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[27]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[28]  A. Coats.  MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? , 2002, International journal of cardiology.

[29]  R. Gibbons,et al.  ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). , 1998, Journal of the American College of Cardiology.

[30]  Gabriel Gregoratos,et al.  心臓ペースメーカー及び抗不整脈デバイスの植込みに関するACC/AHAガイドライン アメリカ合衆国心臓学会/アメリカ心臓協会の診療ガイドラインに関するタスクフォースの報告(ペースメーカー植込みに関する委員会) , 1998 .

[31]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.